PET shows immune-response brain inflammation untied to schizophrenia

Using positron emission tomography (PET), researchers in two separate studies have concluded that, contrary to popular hypothesis, neuroinflammation generated by the brain’s immune system is not directly associated with schizophrenia.

The studies have been published in the American Journal of Psychiatry and NPJ Schizophrenia, and their key findings are nicely summarized at PsychiatryAdvisor.com.

One team of investigators “noted that antipsychotic treatment may factor into their findings,” the website reports, but the other team “did not find evidence of increased microglial activation in antipsychotic medication-free or antipsychotic medication-naive patients either.”

Read the rest: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.